Chemoprevention of Cancer

References

• Doll R, Peto R. The causes of cancer. Oxford University Press, 1981.
   Google Scholar
• Hakama M, Beral V, Cullen JW, Parkin DM, eds. Evaluating effectiveness of primary prevention of cancer. Lyon: IARC Scientific Publications No 103, 1990.
   Google Scholar
• Hakama M, Beral V, Buiatti E, Faivre J, Parkin DM, eds. Chemoprevention in cancer control. Lyon: IARC Scientific Publications No 136, 1996.
   Google Scholar
• Buiatti E, Balzi D, Barchielli A. Intervention trials of cancer prevention: results and new research programmes. Lyon: IARC Technical Report No 18, 1994.
   Google Scholar
• Haenszel W, Segi M. Stomach cancer among the Japanese. In: Harris RJC, ed. Proceedings of the 9th International Cancer Congress, Panels. Heidelberg: Springer-Verlag, 1967: 55–63.
   Google Scholar
• Bjelke E. Epidemiologic studies of cancer of the stomach, colon, and rectum, with special emphasis on the role of diet. Abstracts and Literature Review. Scand J Gastroenterol 1974; 9: 1–235.
   PubMed Web of Science ®Google Scholar
• Doll R. Are we winning the fight against cancer? An epidemi-ological assessment, EACR-Muchlbock Memorial lecture. Eur J Cancer 1990; 26: 500–8.
   PubMed Web of Science ®Google Scholar
• Hakulinen T, Andersen AA, Malker B, Pukkala E, Schou G, Tulinius H. Trends in cancer incidence in the Nordic coun-tries. A collaborative study of the five Nordic Cancer Reg-istries. Helsinki: Acta Pathologica Microbiologica et Immunologica Scandinavica (Suppl 288), 1986.
   Google Scholar
• Cuzick J. Chemoprevention of breast cancer with tamoxifen. In: Hakama M et al., eds. Chemoprevention in cancer con-trol. Lyon: IARC Scientific Publications No 136, 1996; 95–109.
   Google Scholar
• Feigl P, Blumenstein B, Thompson I, et al. Design of the prostate cancer prevention trial (PCPT). Control Clin Trials 1995; 16: 150–63.
   PubMedGoogle Scholar
• Green A. Chemoprevention of skin cancer. In: Hakama M, et al., eds. Chemoprevention in cancer control. Lyon: IARC Scientific Publications No 136, 1996: 111–9.
   Google Scholar
• Gann PH, Manson JE, Glynn RJ. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 1993; 85: 1220–4.
   Google Scholar
• The ATBC study group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029–35.
   PubMed Web of Science ®Google Scholar
• Huttunen JK. Why did antioxidants not protect against lung cancer in the alpha-tocopherol, beta-carotene cancer preven-tion study? In: Hakama M et al., eds. Chemoprevention in cancer control. Lyon: IARC Scientific Publications No 136, 1996; 63–6.
   Google Scholar
• Hennekens CH, Buring JE, Stampfer M, et al. Lack of effect of long-term supplementation with beta-carotene on the inci-dence of malignant neoplasms and the cardiovascular disease. N Engl J Med 1996; 334: 1145–9.
   PubMed Web of Science ®Google Scholar
• Omenn GS, Goodman G, Thornquist M, et al. Chemopreven-tion of lung cancer. The b-carotene and retinol efficacy trial (CARET) on high-risk smokers and asbestos-exposed work-ers. In: Hakama M, et al., eds. Chemoprevention in cancer control. Lyon: IARC Scientific Publications No 136, 1996: 67–86.
   Google Scholar
• Omenn GS, Goodman GE, Thomquist MD, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. New Engl J Med 1996; 334: 1150–5.
   PubMed Web of Science ®Google Scholar
• Early breast cancer trialists' collaborative group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339: 1–15.
   Google Scholar
• Cuzick J. Chemoprevention of breast cancer with tamoxifen. In: Hakama M, et al., eds. Chemoprevention in cancer con-trol. Lyon: IARC Scientific Publications No 136, 1996: 95–110.
   Google Scholar
• Taylor PR, Li B, Dawsey SM, et al. Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Cancer Res 1994; 54: 2029s–31s.
   Google Scholar
• Stewart BW, McGregor D, Kleihues P, eds. Principles of chemoprevention. Lyon: IARC Scientific Publications No 139, 1996.
   Google Scholar
• Habbema JDF, van der Heide A, van den Bosch JMH, Bonneux L. Cost-effectiveness considerations in chemopre-vention of cancer. In: Hakama M, et al., eds. Chemopreven-tion in cancer control. Lyon: IARC Scientific Publications No 136, 1996: 131–8.
   Google Scholar
• Peto R. Epidemiology, multistage models and short-term mutagenicity test. In: Hiatt HH, et al., eds. Origins of human cancer. Vol 4. New York: Cold Spring Harbor Laboratory, 1977: 1403–28.
   Google Scholar
• Day NE, Brown CC. Multistage models and primary preven-tion of cancer. J. Natl Cancer Inst 1980; 64: 977–89.
   PubMed Web of Science ®Google Scholar